U.S. flag

An official website of the United States government

Filters

Other countries

Results: 1 to 8 of 8

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hypersensitivity syndrome, carbamazepine-induced, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-A gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hypersensitivity syndrome, carbamazepine-induced, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Synovitis, chronic, susceptibility to (HLA-B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Toxic epidermal necrolysis, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Stevens-Johnson syndrome, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Drug-induced liver injury due to flucloxacillin (Stevens-Johnson syndrome) (HLA-B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Abacavir hypersensitivity, susceptibility to (HLA-B gene) (HLA Analizi/ HLA Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • T Targeted variant analysis

RightMed Comprehensive Test with Gene Report

OneOme, LLC
United States
225
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Results: 1 to 8 of 8

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.